ANGELA HOWARD: Open Payments
NPI 1639430242 · LEXINGTON, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 9 payments from 6 companies in 2025. Trend: 2023 $72 · 2024 $312 · 2025 $201
Food & beverage: $135Education: $66
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $52 |
| Janssen Biotech, Inc. | 1 | $51 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
Products named: TREMFYA, ZENPEP, ENTYVIO, MAVYRET, VOQUEZNA.
Industry payments across NE — which companies pay providers there.
